Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Chemicals

Rating :
N/A

BSE: 543332 | NSE: EPIGRAL

1966.05
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  2023.10
  •  2040.00
  •  1949.00
  •  2005.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  38250
  •  759.35
  •  2406.75
  •  900.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,473.39
  • 28.87
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,362.50
  • 0.25%
  • 4.89

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.58%
  • 2.84%
  • 18.51%
  • FII
  • DII
  • Others
  • 2.1%
  • 1.06%
  • 3.91%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.55
  • 25.87
  • 7.55

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.14
  • 19.91
  • -1.14

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.90
  • 11.82
  • -8.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 20.31

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 5.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 11.40

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
47.14
70.27
86.03
109.6
P/E Ratio
42.24
28.34
23.14
18.17
Revenue
1929
2480
2877
3454
EBITDA
481
622
732
888
Net Income
196
292
358
455
ROA
7.5
P/Bk Ratio
6.6
5.33
4.27
3.54
ROE
31.18
31
32.9
FCFF
219.18
255.9
271.5
FCFF Yield
2.56
2.99
3.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
626.06
478.15
30.93%
651.20
454.89
43.16%
524.63
562.18
-6.68%
471.52
537.84
-12.33%
Expenses
447.63
370.24
20.90%
474.80
359.70
32.00%
369.24
407.51
-9.39%
348.75
371.31
-6.08%
EBITDA
178.43
107.91
65.35%
176.40
95.19
85.31%
155.39
154.66
0.47%
122.77
166.53
-26.28%
EBIDTM
28.50%
22.57%
27.09%
20.93%
29.62%
27.51%
26.04%
30.96%
Other Income
5.55
1.00
455.00%
2.40
1.52
57.89%
1.52
4.54
-66.52%
2.46
-0.26
-
Interest
27.32
21.27
28.44%
14.25
18.33
-22.26%
13.69
18.99
-27.91%
20.19
21.03
-3.99%
Depreciation
32.25
31.51
2.35%
33.45
30.80
8.60%
30.38
30.13
0.83%
30.88
30.84
0.13%
PBT
124.41
56.13
121.65%
131.10
47.58
175.54%
112.85
110.08
2.52%
74.16
114.40
-35.17%
Tax
43.88
17.95
144.46%
45.09
15.90
183.58%
36.18
33.33
8.55%
24.85
37.20
-33.20%
PAT
80.53
38.18
110.92%
86.01
31.68
171.50%
76.67
76.75
-0.10%
49.31
77.20
-36.13%
PATM
12.86%
7.98%
13.21%
6.96%
14.61%
13.65%
10.46%
14.35%
EPS
19.57
9.14
114.11%
20.67
7.58
172.69%
18.60
18.47
0.70%
11.81
18.58
-36.44%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
2,273.41
1,929.19
2,188.40
1,550.94
828.60
Net Sales Growth
11.82%
-11.84%
41.10%
87.18%
 
Cost Of Goods Sold
1,206.50
1,060.82
1,114.79
761.09
385.32
Gross Profit
1,066.91
868.38
1,073.62
789.85
443.28
GP Margin
46.93%
45.01%
49.06%
50.93%
53.50%
Total Expenditure
1,640.42
1,447.98
1,499.45
1,041.45
567.27
Power & Fuel Cost
-
141.32
153.71
100.23
26.09
% Of Sales
-
7.33%
7.02%
6.46%
3.15%
Employee Cost
-
81.31
68.85
51.99
41.26
% Of Sales
-
4.21%
3.15%
3.35%
4.98%
Manufacturing Exp.
-
84.77
80.49
62.80
43.58
% Of Sales
-
4.39%
3.68%
4.05%
5.26%
General & Admin Exp.
-
28.46
27.65
30.84
48.82
% Of Sales
-
1.48%
1.26%
1.99%
5.89%
Selling & Distn. Exp.
-
25.66
29.36
17.02
4.50
% Of Sales
-
1.33%
1.34%
1.10%
0.54%
Miscellaneous Exp.
-
25.65
24.60
17.49
17.70
% Of Sales
-
1.33%
1.12%
1.13%
2.14%
EBITDA
632.99
481.21
688.95
509.49
261.33
EBITDA Margin
27.84%
24.94%
31.48%
32.85%
31.54%
Other Income
11.93
10.55
9.29
8.34
7.47
Interest
75.45
77.47
66.81
48.50
34.40
Depreciation
126.96
123.56
108.95
85.91
73.54
PBT
442.52
290.72
522.48
383.42
160.86
Tax
150.00
94.88
169.17
130.64
60.02
Tax Rate
33.90%
32.64%
32.38%
34.07%
37.31%
PAT
292.52
195.87
353.29
252.79
100.84
PAT before Minority Interest
292.52
195.87
353.29
252.79
100.84
Minority Interest
0.00
0.00
0.00
0.00
0.00
PAT Margin
12.87%
10.15%
16.14%
16.30%
12.17%
PAT Growth
30.70%
-44.56%
39.76%
150.68%
 
EPS
70.32
47.08
84.93
60.77
24.24

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
1,254.10
1,069.10
725.97
684.13
Share Capital
41.55
41.55
41.55
252.47
Total Reserves
1,212.55
1,027.55
684.42
431.66
Non-Current Liabilities
760.67
715.44
865.41
375.96
Secured Loans
547.04
544.64
768.14
340.47
Unsecured Loans
0.00
0.00
0.00
0.00
Long Term Provisions
4.88
2.72
2.89
1.63
Current Liabilities
779.57
647.69
532.29
388.61
Trade Payables
165.28
110.17
88.11
73.05
Other Current Liabilities
391.25
445.56
354.44
240.33
Short Term Borrowings
221.05
91.71
80.14
75.03
Short Term Provisions
2.00
0.25
9.60
0.20
Total Liabilities
2,794.34
2,432.23
2,123.67
1,448.70
Net Block
1,766.64
1,804.05
1,067.83
1,102.31
Gross Block
2,405.82
2,319.70
1,474.54
1,423.69
Accumulated Depreciation
639.18
515.65
406.71
321.38
Non Current Assets
2,292.41
2,012.74
1,676.72
1,267.41
Capital Work in Progress
482.84
158.10
589.25
125.84
Non Current Investment
20.58
20.55
0.00
0.00
Long Term Loans & Adv.
21.56
30.04
17.85
35.02
Other Non Current Assets
0.79
0.00
1.79
4.24
Current Assets
501.93
419.50
446.94
181.29
Current Investments
0.00
0.00
0.00
0.00
Inventories
262.99
211.83
154.14
53.96
Sundry Debtors
178.75
166.32
256.32
118.84
Cash & Bank
6.80
15.11
25.09
0.68
Other Current Assets
53.39
18.50
3.87
3.16
Short Term Loans & Adv.
12.43
7.74
7.53
4.65
Net Current Assets
-277.64
-228.19
-85.35
-207.32
Total Assets
2,794.34
2,432.24
2,123.66
1,448.70

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
397.64
626.16
283.82
229.22
PBT
290.72
522.48
383.42
160.86
Adjustment
195.85
170.35
130.25
102.62
Changes in Working Capital
-38.40
40.82
-169.41
-5.65
Cash after chg. in Working capital
448.17
733.64
344.27
257.84
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-50.53
-107.48
-60.45
-28.62
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-401.10
-437.22
-454.63
-196.73
Net Fixed Assets
-410.86
-414.01
-514.26
Net Investments
0.05
-20.57
0.00
Others
9.71
-2.64
59.63
Cash from Financing Activity
-7.60
-199.79
195.22
-31.90
Net Cash Inflow / Outflow
-11.06
-10.85
24.41
0.58
Opening Cash & Equivalents
14.24
25.09
0.68
0.10
Closing Cash & Equivalent
3.18
14.24
25.09
0.68

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
301.83
257.30
174.72
113.88
ROA
7.50%
15.51%
14.15%
6.96%
ROE
16.86%
39.36%
42.16%
21.31%
ROCE
17.69%
32.20%
29.40%
15.97%
Fixed Asset Turnover
0.85
1.22
1.11
0.61
Receivable days
31.43
33.28
42.65
50.07
Inventory Days
43.24
28.81
23.66
22.74
Payable days
47.39
32.46
38.64
69.20
Cash Conversion Cycle
27.28
29.63
27.66
3.61
Total Debt/Equity
0.77
0.82
1.36
0.79
Interest Cover
4.75
8.82
8.91
5.68

News Update:


  • Epigral to double production capacity at Dahej
    11th Nov 2024, 14:40 PM

    The Board of Directors of the Company at their meeting held on November 09, 2024 has approved the same

    Read More
  • Epigral - Quarterly Results
    9th Nov 2024, 12:58 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.